American Association for Cancer Research
Browse
00085472can131310-sup-fig1-3.pdf (612.05 kB)

Supplementary Figures 1 - 3 from MAPK Kinase 3 Is a Tumor Suppressor with Reduced Copy Number in Breast Cancer

Download (612.05 kB)
journal contribution
posted on 2023-03-30, 22:08 authored by Adam J. MacNeil, Shun-Chang Jiao, Lori A. McEachern, Yong Jun Yang, Amanda Dennis, Haiming Yu, Zhaolin Xu, Jean S. Marshall, Tong-Jun Lin

PDF file - 612K, Supplementary Figure S1. Correlation of genomic loss and mRNA expression in breast cancer patients. Supplementary Figure S2. Generation of stable MDA-MB-468 cell lines expressing MKK3dn or MKK3ca. Supplementary Figure S3. MKK3 signalling inhibits Akt activation in MDA-MB-468 cells.

History

ARTICLE ABSTRACT

Cancers are initiated as a result of changes that occur in the genome. Identification of gains and losses in the structure and expression of tumor-suppressor genes and oncogenes lies at the root of the understanding of cancer cell biology. Here, we show that the mitogen–activated protein kinase (MAPK) MKK3 suppresses the growth of breast cancer, in which it varies in copy number. A pervasive loss of MKK3 gene copy number in patients with breast cancer is associated with an impairment of MKK3 expression and protein level in malignant tissues. To assess the functional role of MKK3 in breast cancer, we showed in an animal model that MKK3 activity is required for suppression of tumor growth. Active MKK3 enhanced expression of the cyclin-dependent kinase inhibitors p21Cip1/Waf1 and p27Kip1, leading to increased cell-cycle arrest in G1 phase of the cell cycle. Our results reveal the functional significance of MKK3 as a tumor suppressor and improve understanding of the dynamic role of the MAPK pathway in tumor progression. Cancer Res; 74(1); 162–72. ©2013 AACR.